Phase I trial and pharmacokinetic (PK) study of ABT-751, an orally bioavailable tubulin binding agent, in pediatric patients with refractory solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2080-2080 ◽  
Author(s):  
S. Y. Cho ◽  
P. C. Adamson ◽  
A. E. Hagey ◽  
B. C. Widemann ◽  
J. M. Maris ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Binding Agent ◽  
Tubulin Binding ◽  
Orally Bioavailable

Phase I trial and pharmacokinetic (PK) study of ABT-751, an orally bioavailable tubulin binding agent, in pediatric patients with refractory solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2080-2080 ◽  
Author(s):  
S. Y. Cho ◽  
P. C. Adamson ◽  
A. E. Hagey ◽  
B. C. Widemann ◽  
J. M. Maris ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Binding Agent ◽  
Tubulin Binding ◽  
Orally Bioavailable

A phase I trial and pharmacokinetic study of gefitinib in pediatric patients with refractory solid tumors: A Children's Oncology Group Study

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8522-8522
Author(s):  
N. C. Daw ◽  
W. L. Furman ◽  
C. F. Stewart ◽  
L. C. Iacono ◽  
M. Krailo ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Oncology Group ◽  
Oncology Group Study

Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors

2006 ◽  
Vol 47 (2) ◽  
pp. 163-168 ◽  
Author(s):  
Lisa R. Bomgaars ◽  
Gail C. Megason ◽  
Jeanette Pullen ◽  
Anne-Marie Langevin ◽  
Steve Dale Weitman ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Mgi 114

A phase I trial and pharmacokinetic study of gefitinib in pediatric patients with refractory solid tumors: A Children's Oncology Group Study

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8522-8522 ◽  
Author(s):  
N. C. Daw ◽  
W. L. Furman ◽  
C. F. Stewart ◽  
L. C. Iacono ◽  
M. Krailo ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Oncology Group ◽  
Oncology Group Study

scholarly journals A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors

2008 ◽  
Vol 14 (4) ◽  
pp. 1111-1115 ◽  
Author(s):  
Elizabeth Fox ◽  
John M. Maris ◽  
Brigitte C. Widemann ◽  
Wendy Goodspeed ◽  
Anne Goodwin ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Pediatric Patients ◽  
Tubulin Inhibitor ◽  
Orally Bioavailable

scholarly journals Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors

2004 ◽  
Vol 10 (3) ◽  
pp. 840-848 ◽  
Author(s):  
Lars M. Wagner ◽  
Kristine R. Crews ◽  
Lisa C. Iacono ◽  
Peter J. Houghton ◽  
Christine E. Fuller ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Pediatric Patients

Lexatumumab: Results of a phase I trial in pediatric patients with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 9500-9500 ◽  
Author(s):  
M. S. Merchant ◽  
A. J. Chou ◽  
A. Price ◽  
J. I. Geller ◽  
M. Tsokos ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Advanced Solid Tumors

Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors

2007 ◽  
Vol 49 (3) ◽  
pp. 352-357 ◽  
Author(s):  
Antonio Jimeno ◽  
Najat C. Daw ◽  
Maria L. Amador ◽  
George Cusatis ◽  
Peter Kulesza ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Pediatric Patients ◽  
Surrogate Markers ◽  
Oncology Group
Sign in / Sign up

Export Citation Format

Share Document